Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Liabilities from Discontinued Operations (2016)

Lisata Therapeutics' Liabilities from Discontinued Operations history spans 3 years, with the latest figure at 10925052.0 for Q4 2016.

  • For Q4 2016, Liabilities from Discontinued Operations changed N/A year-over-year to 10925052.0; the TTM value through Dec 2016 reached 10925052.0, changed N/A, while the annual FY2016 figure was 10925052.0, N/A changed from the prior year.
  • Liabilities from Discontinued Operations reached 10925052.0 in Q4 2016 per LSTA's latest filing, down from 39343867.0 in the prior quarter.
  • In the past five years, Liabilities from Discontinued Operations ranged from a high of 39343867.0 in Q3 2012 to a low of 10925052.0 in Q4 2016.